Logistic Regression Model (Limited)

Slides:



Advertisements
Similar presentations
Karam Paul MS, MD, MBA, FACC Community Heart and Vascular.
Advertisements

Lipid Management in 2015: Risk & Controversies
Change in Abdominal Obesity & Risk of Coronary Calcification Siamak Sabour, MD, MSc, DSc, PhD, Postdoc Clinical Epidemiologist Persian International Epidemiology.
A Noninvasive, Hand-Held Device for Assessing Left Ventricular End-Diastolic Pressure Based on Finger Photoplethysmography and the Valsalva Maneuver Panagis.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
Coronary Heart Disease Prevalence DR. MOHAMMED O. AL-RUKBAN Assistant Professor Department of Family and Community Medicine College of Medicine, King Saud.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Health Monitoring Tests
1 Comparing Zero Coronary Artery Calcium With Other Negative Risk Factors for Coronary Heart Disease A Novel Methodology: Risk-Adjusted Negative Likelihood.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
SENSORS AND SCATTERPLOTS Introduction. BODY MASS INDEX (BMI)  BMI is a number calculated from your weight and height. BMI = (weight, kg) (height, m)
Blood Pressure Control By Randomized Drug Group In ALLHAT William C. Cushman, Charles E. Ford, Paula T. Einhorn, Jackson T. Wright, Jr., Richard A. Preston,
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Clinical Trial Results. org Long-Term Prognosis Associated with Coronary Calcification Matthew J. Budoff, MD, Leslee J. Shaw, PhD, Sandy T. Liu, Steven.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.
Ethnic Differences in the Prognostic Value of Coronary Artery Calcification for All-Cause Mortality Khurram Nasir MD MPH, Leslee J. Shaw PhD, Sandy T.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Acknowledgements Contact Information Anthony Wong, MTech 1, Senthil K. Nachimuthu, MD 1, Peter J. Haug, MD 1,2 Patterns and Rules  Vital signs medoids.
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Cardiac Autonomic Neuropathy in Type 2 Diabetes: Predicting Cardiac Risk Margaret M. McCarthy 1 Lawrence Young 2 Silvio Inzucchi 2 Janice Davey 2 Frans.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
○ South Asians (SAs) have high rates of CHD which are not entirely explained by traditional CVD risk factors. ○ The association of a family history of.
Indication Contraindication Preparation
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
Category Sex Systolic BP (mmHg) Men (n=58) Women (n=106) P value
Bootstrap and Model Validation
Zoll Firm Lecture Series
An analysis of 22,672 patients from the CLARIFY registry
ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy From ESH 2016 | LB 1: Jean-Pierre Fauvel, MD CHU Lyon, Hôpital E Herriot,
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
From ESH 2016 | LB 3: Davide Agnoletti, MD
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
Background/Objective
Results from the intermountain heart collaborative study
Baseline characteristics and effectiveness results
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Artificial Neural Network based model enhances risk.
Nursing Care of Patients with Hypertension
John Weeks1, MD Candidate 2017, Justin Hickman1, MD Candidate 2017
Exercise Adherence in Patients with Diabetes: Evaluating the role of psychosocial factors in managing diabetes Natalie N. Young,1, 2 Jennifer P. Friedberg,1,
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Feasibility and safety of exercise stress testing using.
Health and Human Services National Heart, Lung, and Blood Institute
The Intermountain heart collaborative study
All-cause mortality by treatment group
Alina M. Allen MD, Patrick S. Kamath MD, Joseph J. Larson,
CASE HISTORY ISCHEMIC HEART DISEASE
BACKGROUND RESULTS OBJECTIVES METHODS CONCLUSIONS REFERENCES
Machine Learning Outperformed ACC/AHA Pooled Cohort Equations Risk Calculator for Detection of High-Risk Asymptomatic Individuals and Recommending Treatment.
Higher Fitness Is Strongly Protective in Patients with Family History of Heart Disease: The FIT Project  Mahmoud Al Rifai, MD, MPH, Jaideep Patel, MD,
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
Intensive Observation Unit Careggi University Hospital, Firenze Italy
Dominique Hansen, PhD, FESC
Use of the Coronary Artery Calcium Score in Discussion of Initiation of Statin Therapy in Primary Prevention  Erin D. Michos, MD, MHS, Michael J. Blaha,
Higher Fitness Is Strongly Protective in Patients with Family History of Heart Disease: The FIT Project  Mahmoud Al Rifai, MD, MPH, Jaideep Patel, MD,
WHI Observational Study: Cardiovascular death in women with hypertension but no history of CVD on monotherapy CVD death Diuretic, HR (95% CI) ACE inhibitor,
Prevalence of statin and beta-blocker use by clinical presentation
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
Volume 14, Issue 12, Pages (December 2017)
Maximal Estimated Cardiorespiratory Fitness, Cardiometabolic Risk Factors, and Metabolic Syndrome in the Aerobics Center Longitudinal Study  Conrad P.
Preventative Cardiology
Gabriel E. Shaya, MS, Mouaz H. Al-Mallah, MD, MSc, Rupert K
Is There an “Asymptote of Gain” Beyond Which Further Increases in Cardiorespiratory Fitness Convey No Additional Benefits on Mortality and Atrial Fibrillation? 
Associations between type of MI and incident HF
Risk of cardiovascular disease mortality by cardiorespiratory fitness and body mass index categories, 2316 men with type 2 diabetes at baseline, 179 deaths.
Predictive Validity of a Medical-Related Cardiorespiratory Fitness Algorithm in Predicting Cardiovascular Disease– and All-Cause Mortality: Implications.
Presentation transcript:

Logistic Regression Model (Limited) Using Machine Learning to Define the Association between Cardiorespiratory Fitness and All-Cause Mortality: The FIT (Henry Ford ExercIse Testing) Project Mouaz H. Al-Mallah MD, MSc1,2; Radwa Elshawi, PhD3; Amjad M. Ahmed, MBBS MSc2; Waqas T. Qureshi, MD MS4; Clinton A. Brawner, PhD1; Michael J. Blaha, MD MPH5; Haitham M. Ahmed, MD MPH5, 6; Jonathan K. Ehrman, PhD1; Steven J. Keteyian PhD1; Sherif Sakr PhD2 1: Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, MI, USA; 2: King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, King AbdulAziz Cardiac Center, Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; 3:Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 4:Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, USA; 5: Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA; 6: Cleveland Clinic Foundation, Cleveland, OH, USA Prior studies have demonstrated that cardiorespiratory fitness (CRF) is a strong marker of cardiovascular health. Machine learning (ML) can enhance the prediction of outcomes through classification technique that classifies the data into predetermined categories. The aim of the analysis is to compare the prediction of 10 year all-cause mortality (ACM) using logistic regression (LR) and ML approaches in patients who underwent stress testing. A total of 34,212 patients (Mean age 54 ± 13 years, 55% males) were included in this analysis. The baseline characteristics of the included cohort are shown in the table below showing high prevalence of cardiovascular risk factors. During a follow-up duration of 10 years, a total of 3,921 patients (11.5%) died. Feature selection for potential inclusion in the machine learning model: METs: Metabolic Equivalent of Tasks; %HR: Percentage of Heart Rate; SBP: Systolic Blood Pressure; CHD: Coronary Heart Disease. Accuracy to Predict 10-year all-cause mortality using ASCVD risk score, Logistic regression or Machine learning approaches Table 1. Baseline Characteristics of the cohort   Logistic Regression Model (Limited) Machine Learning True Positive 1,669 3,427 False Positive 2,144 846 False Negative 2,252 494 True Negative 18,117 29,445 Sensitivity 42.57% (41.0% -44.1%) 87.4% (86.3% - 88.4%) Specificity 93.02 %(92.7% - 93.3%) 97.2% (97.0% - 97.4%) Positive Likelihood Ratio 6.10 (5.77 - 6.44) 31.3 (29.3 - 33.5) Negative Likelihood Ratio 0.62 (0.60 - 0.63) 0.13 (0.12 - 0.14) Positive Predictive Value 44.12% (42.8% to 45.5%) 80.20% (79.0% - 81.4%) Negative Predictive Value 92.6% (92.4% to 92.8 %) 98.35% (98.2% - 98.5%) Model Area Under the Curve 0.824 (0.815 - 0.830) 0.923 (0.917 - 0.928) Characteristic Data (n=34,212) Age (years)* 54 ± 13 Male $ 18,703 (55) Race $   White 23801 (70) Black 9768 (29) Others 643 (1) Body Mass Index (kg/m2) * 29.3 ± 5.8 Reason for Test $ Chest Pain 17547 (51) Shortness of Breath 3307 (10) Pre-Operation 781 (2) Rule out Ischemia 3884 (11) Stress Variables * Peak METS 9.2 ± 3.1 Resting Systolic Blood Pressure (mmHg) 132 ± 19 Resting Diastolic Blood Pressure (mmHg) 82 ± 11 Resting Heart rate (bpm) 74 ± 13 Peak Systolic Blood Pressure (mmHg) 183 ± 27 Peak Diastolic Blood Pressure (mmHg) 86 ± 14 Peak Heart Rate (bpm) 151 ± 21 Chronotropic incompetence $ 6,957 (23.3) Past Medical History $ Diabetes 5,907(17) Hypertension 20,534 (60) Smoking 15,249 (43) Family History of CAD 18,299 (51) Medications Used $ Diuretic Use 5,743 (16) Hypertensive medications 14,905 (42) Diabetes medications 2,432 (7) Statin 4,524 (13.2) Aspirin 5,752 (16.8) Beta Blockers 5,434 (15.9) Calcium Channel Blockers 4,638 (13.5) All the data are presented as: * Mean and standard deviation and $ frequencies and percentages. mmHg: millimeter mercury; bpm: beat per minute; CAD: coronary artery disease. We included 34,212 patients (55% males, mean age 54 ± 13years) free of coronary artery disease or heart failure who underwent clinician-referred exercise treadmill stress testing at Henry Ford Health Systems Between 1991 and 2009 and had complete 10-year follow-up. The primary outcome of this analysis was All Cause Mortality at 10 years. The machine learning Methods used was K-Nearest Neighbors algorithm (K-NN) classification technique; K-NN algorithm is a supervised classification technique where the training dataset is used by the classifier to train the model about how items from class “Yes” and from class “No” look like. The probability of 10 year ACM was calculated using logistic regression, ASCVD risk score and machine learning technique and the accuracy of these methods was calculated and compared. Our analysis demonstrates that ML provides better accuracy and discrimination of the prediction of ACM among patients undergoing stress testing compared to LR. To the best of our knowledge, this is the first report describing the ML approach for interpreting a large dataset using exercise stress test variables to identify individuals at risk of ACM in individuals without known CVD Machine learning had the highest Area under the Curve (AUC 0.923) in the prediction of all-cause mortality compared to logistic regression (AUC 0.824) or atherosclerotic cardiovascular disease (ASCVD) risk score (AUC 0.785), p < 0.001 Disclosures: None